In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF

Sergio Huerta, Guillermina Baay-Guzman, Cesar R. Gonzalez-Bonilla, Edward H. Livingston, Sara Huerta-Yepez, Benjamin Bonavida

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Tumor cells develop mechanisms that dysregulate apoptotic pathways resulting in resistance to cytotoxic stimuli. Primary SW480 and metastatic SW620 colon cancer cells are resistant to CDDP-induced apoptosis. Apoptosis-inducing factor (AIF) was significantly downregulated in SW620 compared to SW480 cells; while apoptotic mediators such as Bax, Bcl-2, and BclXL were not altered in these cell lines. Examination of tumor tissues from patients with colon cancer demonstrated a significant downregulation of AIF in patients with advanced disease. The role of AIF expression in resistance was examined. Several lines of evidence suggest the involvement of AIF expression level in the sensitivity of SW620 to CDDP-induced apoptosis: (1) sensitization of SW620 by the NO donor DETANONOate to CDDP-induced apoptosis correlated with the induction of AIF as assessed by RT-PCR and Western blot analysis, (2) treatment of SW620 cells with siRNA AIF, but not with control siRNAs, inhibited DETANONOate-induced sensitization to CDDP apoptosis, (3) sensitization by DETANONOate observed in vitro was corroborated in vivo in nude mice bearing SW620 tumor xenografts and treated with the combination of DETANONOate and CDDP, and (4) tumor tissues derived from the SW620 xenografts revealed significant upregulation of AIF and increased apoptosis by DETANONOate and CDDP combination treatment. Altogether, these findings underscore the potential therapeutic application of NO donors and subtoxic chemotherapeutic drugs in the treatment of advanced colon cancer resistant to conventional chemotherapeutic agents.

Original languageEnglish (US)
Pages (from-to)182-194
Number of pages13
JournalNitric Oxide - Biology and Chemistry
Volume20
Issue number3
DOIs
StatePublished - Apr 15 2009

Fingerprint

Apoptosis Inducing Factor
Nitric Oxide Donors
Colonic Neoplasms
Cells
Apoptosis
Tumors
Heterografts
Neoplasms
Bearings (structural)
Down-Regulation
Tissue
Therapeutics
In Vitro Techniques
2,2'-(hydroxynitrosohydrazono)bis-ethanamine
Nude Mice
Small Interfering RNA
Up-Regulation
Western Blotting
Cell Line
Polymerase Chain Reaction

Keywords

  • Apoptosis
  • Chemoresistance
  • Colon cancer
  • DETANONOate
  • Nitric oxide donors

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Cancer Research
  • Physiology

Cite this

In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate : Involvement of AIF. / Huerta, Sergio; Baay-Guzman, Guillermina; Gonzalez-Bonilla, Cesar R.; Livingston, Edward H.; Huerta-Yepez, Sara; Bonavida, Benjamin.

In: Nitric Oxide - Biology and Chemistry, Vol. 20, No. 3, 15.04.2009, p. 182-194.

Research output: Contribution to journalArticle

Huerta, Sergio ; Baay-Guzman, Guillermina ; Gonzalez-Bonilla, Cesar R. ; Livingston, Edward H. ; Huerta-Yepez, Sara ; Bonavida, Benjamin. / In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate : Involvement of AIF. In: Nitric Oxide - Biology and Chemistry. 2009 ; Vol. 20, No. 3. pp. 182-194.
@article{b7d5cd08e0044f0ba5a5cbbb9673be76,
title = "In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF",
abstract = "Tumor cells develop mechanisms that dysregulate apoptotic pathways resulting in resistance to cytotoxic stimuli. Primary SW480 and metastatic SW620 colon cancer cells are resistant to CDDP-induced apoptosis. Apoptosis-inducing factor (AIF) was significantly downregulated in SW620 compared to SW480 cells; while apoptotic mediators such as Bax, Bcl-2, and BclXL were not altered in these cell lines. Examination of tumor tissues from patients with colon cancer demonstrated a significant downregulation of AIF in patients with advanced disease. The role of AIF expression in resistance was examined. Several lines of evidence suggest the involvement of AIF expression level in the sensitivity of SW620 to CDDP-induced apoptosis: (1) sensitization of SW620 by the NO donor DETANONOate to CDDP-induced apoptosis correlated with the induction of AIF as assessed by RT-PCR and Western blot analysis, (2) treatment of SW620 cells with siRNA AIF, but not with control siRNAs, inhibited DETANONOate-induced sensitization to CDDP apoptosis, (3) sensitization by DETANONOate observed in vitro was corroborated in vivo in nude mice bearing SW620 tumor xenografts and treated with the combination of DETANONOate and CDDP, and (4) tumor tissues derived from the SW620 xenografts revealed significant upregulation of AIF and increased apoptosis by DETANONOate and CDDP combination treatment. Altogether, these findings underscore the potential therapeutic application of NO donors and subtoxic chemotherapeutic drugs in the treatment of advanced colon cancer resistant to conventional chemotherapeutic agents.",
keywords = "Apoptosis, Chemoresistance, Colon cancer, DETANONOate, Nitric oxide donors",
author = "Sergio Huerta and Guillermina Baay-Guzman and Gonzalez-Bonilla, {Cesar R.} and Livingston, {Edward H.} and Sara Huerta-Yepez and Benjamin Bonavida",
year = "2009",
month = "4",
day = "15",
doi = "10.1016/j.niox.2008.11.006",
language = "English (US)",
volume = "20",
pages = "182--194",
journal = "Nitric Oxide - Biology and Chemistry",
issn = "1089-8603",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate

T2 - Involvement of AIF

AU - Huerta, Sergio

AU - Baay-Guzman, Guillermina

AU - Gonzalez-Bonilla, Cesar R.

AU - Livingston, Edward H.

AU - Huerta-Yepez, Sara

AU - Bonavida, Benjamin

PY - 2009/4/15

Y1 - 2009/4/15

N2 - Tumor cells develop mechanisms that dysregulate apoptotic pathways resulting in resistance to cytotoxic stimuli. Primary SW480 and metastatic SW620 colon cancer cells are resistant to CDDP-induced apoptosis. Apoptosis-inducing factor (AIF) was significantly downregulated in SW620 compared to SW480 cells; while apoptotic mediators such as Bax, Bcl-2, and BclXL were not altered in these cell lines. Examination of tumor tissues from patients with colon cancer demonstrated a significant downregulation of AIF in patients with advanced disease. The role of AIF expression in resistance was examined. Several lines of evidence suggest the involvement of AIF expression level in the sensitivity of SW620 to CDDP-induced apoptosis: (1) sensitization of SW620 by the NO donor DETANONOate to CDDP-induced apoptosis correlated with the induction of AIF as assessed by RT-PCR and Western blot analysis, (2) treatment of SW620 cells with siRNA AIF, but not with control siRNAs, inhibited DETANONOate-induced sensitization to CDDP apoptosis, (3) sensitization by DETANONOate observed in vitro was corroborated in vivo in nude mice bearing SW620 tumor xenografts and treated with the combination of DETANONOate and CDDP, and (4) tumor tissues derived from the SW620 xenografts revealed significant upregulation of AIF and increased apoptosis by DETANONOate and CDDP combination treatment. Altogether, these findings underscore the potential therapeutic application of NO donors and subtoxic chemotherapeutic drugs in the treatment of advanced colon cancer resistant to conventional chemotherapeutic agents.

AB - Tumor cells develop mechanisms that dysregulate apoptotic pathways resulting in resistance to cytotoxic stimuli. Primary SW480 and metastatic SW620 colon cancer cells are resistant to CDDP-induced apoptosis. Apoptosis-inducing factor (AIF) was significantly downregulated in SW620 compared to SW480 cells; while apoptotic mediators such as Bax, Bcl-2, and BclXL were not altered in these cell lines. Examination of tumor tissues from patients with colon cancer demonstrated a significant downregulation of AIF in patients with advanced disease. The role of AIF expression in resistance was examined. Several lines of evidence suggest the involvement of AIF expression level in the sensitivity of SW620 to CDDP-induced apoptosis: (1) sensitization of SW620 by the NO donor DETANONOate to CDDP-induced apoptosis correlated with the induction of AIF as assessed by RT-PCR and Western blot analysis, (2) treatment of SW620 cells with siRNA AIF, but not with control siRNAs, inhibited DETANONOate-induced sensitization to CDDP apoptosis, (3) sensitization by DETANONOate observed in vitro was corroborated in vivo in nude mice bearing SW620 tumor xenografts and treated with the combination of DETANONOate and CDDP, and (4) tumor tissues derived from the SW620 xenografts revealed significant upregulation of AIF and increased apoptosis by DETANONOate and CDDP combination treatment. Altogether, these findings underscore the potential therapeutic application of NO donors and subtoxic chemotherapeutic drugs in the treatment of advanced colon cancer resistant to conventional chemotherapeutic agents.

KW - Apoptosis

KW - Chemoresistance

KW - Colon cancer

KW - DETANONOate

KW - Nitric oxide donors

UR - http://www.scopus.com/inward/record.url?scp=61849182029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849182029&partnerID=8YFLogxK

U2 - 10.1016/j.niox.2008.11.006

DO - 10.1016/j.niox.2008.11.006

M3 - Article

C2 - 19105980

AN - SCOPUS:61849182029

VL - 20

SP - 182

EP - 194

JO - Nitric Oxide - Biology and Chemistry

JF - Nitric Oxide - Biology and Chemistry

SN - 1089-8603

IS - 3

ER -